Medical News

RSS

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

iMedicor and Transgenomic today announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease.

15 Sep 2009

Implantable defibrillator therapy not beneficial for women with heart failure

Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that the company’s Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at a bifurcation in patients with heart disease.

15 Sep 2009

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

The National Minority Quality Forum (NMQF), one of the nation's leading voices in the health disparities discussion, is launching the P.A.D. Atlas, a database that maps by zip code peripheral arterial disease (P.A.D.) prevalence down to the street level, with the P.A.D. Coalition and support from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

15 Sep 2009

Mantra medicine tool helps patients in healing process

Dr. Mitchell Earl Gibson, a board-certified medical doctor in High Point, North Carolina, has formed a company that creates mantra and prayer-meditation-based recordings.

15 Sep 2009

Halozyme Therapeutics to present its product development pipeline

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.

15 Sep 2009

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.

15 Sep 2009

New hydrogel mats extends anti-infection protection

Treatment of hospital-related infections in the U.S. costs up to $11 billion a year and about half of those infections are related to medical devices implanted in patients. Until now, efforts to control drug-resistant biofilms on such devices have been largely unsuccessful.

15 Sep 2009

RAPS honors award recipients for contributions to healthcare product regulatory profession

The Regulatory Affairs Professionals Society (RAPS) today honored the recipients of its prestigious awards for outstanding contributions to the healthcare product regulatory profession. RAPS' Leonard Stauffer Award for mentoring and furthering regulatory professional education was given to independent consultant Nanci Dexter.

15 Sep 2009

RED Light energy drink aims to add more corporate accounts

In a market saturated with energy drinks and shots, entrepreneur Paul Ebrahimian knew he was in for a challenge when he founded RED Light(R). However, he had the recipe for a great-tasting beverage, a smart business plan in place and the marketing vision to position RED Light as THE drink of choice--not just for energy, but also as an elixir.

15 Sep 2009

The University City Science Center contributes significantly to regional economy

Graduate organizations and current residents of the University City Science Center’s business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually, according to a study measuring the economic impact of the Science Center’s business incubation services that was released September 14, 2009.

15 Sep 2009

HTDS denies allegations of issuers regarding improper promotions

HTDS- The issuers received a certain e-mail after the market closed on September 14 2009 where amongst other things Pink Sheets claims that it has received complaints about improper promotions.

15 Sep 2009

Elekta announces interim results

Demand for Elekta’s clinical solutions, products and services remained strong in the first three months of 2009/10. Order bookings rose by 19 percent in local currency with solid performance in all regions. Net sales grew to SEK 1,440 M and operating result rose to SEK 89 M. Earnings per share improved to SEK 0.62 from SEK 0.02.

From Elekta 15 Sep 2009

Extension study data on Fampridine-SR drug

Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.

15 Sep 2009

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

CPEX Pharmaceuticals, Inc. (“CPEX”) today announced that it will participate in the Ninth Annual Diabetes Technology Meeting to be held November 5–7, 2009, at the Hyatt Regency Airport in San Francisco, California. Dr. Lance Berman, Senior Vice President and Chief Medical Officer, is scheduled to present an oral presentation titled “The Technology and Clinical Aspects of Nasal Insulin Therapy” at 9:30 a.m. PST on Saturday, November 7, 2009.

15 Sep 2009

Alnylam and Medtronic announce pre-clinical research findings from their Huntington’s disease program

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT), the world’s leading developer of medical devices, announced today the presentation of new pre-clinical research findings from their Huntington’s disease program at the 2009 World Congress on Huntington’s Disease held September 12-15, 2009 in Vancouver, British Columbia.

15 Sep 2009

Conference on how American auto industry's future could affect UAW patients

A conference to explore how the future of the American auto industry could affect United Auto Workers (UAW) patients and their physicians and dentists will be presented by the Michigan State Medical Society and the Michigan Dental Association on Thursday, Sept. 17, from Noon to 4:30 p.m. at the Rock Financial Showplace in Novi.

15 Sep 2009

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.

15 Sep 2009

Winner of 2009 Annie E. Casey Innovations Award announced

The Ash Institute for Democratic Governance and Innovation at the John F. Kennedy School of Government at Harvard University today announced Wraparound Milwaukee of Milwaukee County as the 2009 winner of the Annie E. Casey Innovations Award in Children and Family System Reform. As part of Milwaukee County’s Department of Health and Human Services, Wraparound Milwaukee is the first government-operated managed care service designed to treat emotionally disturbed youth in the home setting.

15 Sep 2009

Medical News

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

Implantable defibrillator therapy not beneficial for women with heart failure

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

Mantra medicine tool helps patients in healing process

Halozyme Therapeutics to present its product development pipeline

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

New hydrogel mats extends anti-infection protection

RAPS honors award recipients for contributions to healthcare product regulatory profession

RED Light energy drink aims to add more corporate accounts

The University City Science Center contributes significantly to regional economy

HTDS denies allegations of issuers regarding improper promotions

Elekta announces interim results

Extension study data on Fampridine-SR drug

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

Alnylam and Medtronic announce pre-clinical research findings from their Huntington’s disease program

Conference on how American auto industry's future could affect UAW patients

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

Winner of 2009 Annie E. Casey Innovations Award announced

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News